{"schema_version":"secwatch.filing_event.v1","accession":"0001178913-26-002797","form_type":"8-K","ticker":"LFWD","cik":"0001607962","company_name":"Lifeward Ltd.","filed_at":"2026-05-19T12:37:24+00:00","discovered_at":"2026-05-19T12:40:00.291064+00:00","generated_at":"2026-05-19T12:41:21.525096+00:00","sec_items":["8.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Lifeward appoints Keith D. Rose as Chief Medical Officer effective May 1, 2026","bullets":["Keith D. Rose, M.D. appointed Chief Medical Officer effective May 1, 2026.","Dr. Rose joined Lifeward in March 2023; most recently VP, Medical Affairs, Medical Director – Neurosciences.","Prior experience includes Medical Director at Biocodex and Clinical Research Scientist at Novocure (NVCR).","Holds M.D. from George Washington University; residency at Baylor College of Medicine."],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-26-002797","json":"https://secwatch.observer/filing/0001178913-26-002797.json","markdown":"https://secwatch.observer/filing/0001178913-26-002797.md","text":"https://secwatch.observer/filing/0001178913-26-002797.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1607962/000117891326002797/0001178913-26-002797-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1607962/000117891326002797/zk2635366.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T12:41:21.525096+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}